More importantly, this study provides a new concept that the MAPK pathway is involved in HG-induced RAS activation and renal fibrosis via regulation of ACE expression in the development of DN, indicating that reduction in ACE expression by MAPKs inhibition seems to be an alternative strategy for the treatment of DN. The gene discussed is ACE; the disease is liver dysplastic nodule.